Cargando…

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia

Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jongmin, Kim, Yong Hyun, Kang, Ji Young, Jegal, Yangjin, Park, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778744/
https://www.ncbi.nlm.nih.gov/pubmed/31172700
http://dx.doi.org/10.4046/trd.2018.0092
_version_ 1783456811536351232
author Lee, Jongmin
Kim, Yong Hyun
Kang, Ji Young
Jegal, Yangjin
Park, So Young
author_facet Lee, Jongmin
Kim, Yong Hyun
Kang, Ji Young
Jegal, Yangjin
Park, So Young
author_sort Lee, Jongmin
collection PubMed
description Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Clinical manifestations include subacute or chronic dyspnea and cough that last an average of 6 months, most of which occur in non-smoking, middle-aged women. The common findings in thoracic high-resolution computed tomography in NSIP are bilateral reticular opacities, traction bronchiectasis, reduced volume of the lobes, and ground-glass opacity in the lower lungs. These lesions can involve diffuse bilateral lungs or subpleural area. Unlike usual interstitial pneumonia, honeycombing is sparse or absent. Pathology shows diffuse interstitial inflammation and fibrosis which are temporally homogeneous, namely NSIP pattern. Idiopathic NSIP is usually treated with steroid only or combination with immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine, and mycophenolate mofetil. Prognosis of idiopathic NSIP is better than idiopathic pulmonary fibrosis. Many studies have reported a 5-year survival rate of more than 70%.
format Online
Article
Text
id pubmed-6778744
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format MEDLINE/PubMed
spelling pubmed-67787442019-10-10 Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia Lee, Jongmin Kim, Yong Hyun Kang, Ji Young Jegal, Yangjin Park, So Young Tuberc Respir Dis (Seoul) Review Article Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Clinical manifestations include subacute or chronic dyspnea and cough that last an average of 6 months, most of which occur in non-smoking, middle-aged women. The common findings in thoracic high-resolution computed tomography in NSIP are bilateral reticular opacities, traction bronchiectasis, reduced volume of the lobes, and ground-glass opacity in the lower lungs. These lesions can involve diffuse bilateral lungs or subpleural area. Unlike usual interstitial pneumonia, honeycombing is sparse or absent. Pathology shows diffuse interstitial inflammation and fibrosis which are temporally homogeneous, namely NSIP pattern. Idiopathic NSIP is usually treated with steroid only or combination with immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine, and mycophenolate mofetil. Prognosis of idiopathic NSIP is better than idiopathic pulmonary fibrosis. Many studies have reported a 5-year survival rate of more than 70%. The Korean Academy of Tuberculosis and Respiratory Diseases 2019-10 2019-05-31 /pmc/articles/PMC6778744/ /pubmed/31172700 http://dx.doi.org/10.4046/trd.2018.0092 Text en Copyright©2019. The Korean Academy of Tuberculosis and Respiratory Diseases http://creativecommons.org/licenses/by-nc/4.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Review Article
Lee, Jongmin
Kim, Yong Hyun
Kang, Ji Young
Jegal, Yangjin
Park, So Young
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title_full Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title_fullStr Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title_full_unstemmed Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title_short Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
title_sort korean guidelines for diagnosis and management of interstitial lung diseases: part 3. idiopathic nonspecific interstitial pneumonia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778744/
https://www.ncbi.nlm.nih.gov/pubmed/31172700
http://dx.doi.org/10.4046/trd.2018.0092
work_keys_str_mv AT leejongmin koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia
AT kimyonghyun koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia
AT kangjiyoung koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia
AT jegalyangjin koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia
AT parksoyoung koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia
AT koreanguidelinesfordiagnosisandmanagementofinterstitiallungdiseasespart3idiopathicnonspecificinterstitialpneumonia